Akebia Therapeutics Inc (NASDAQ:AKBA)

0.4072
Delayed Data
As of 3:59pm ET
 -0.0095 / -2.28%
Today’s Change
0.30
Today|||52-Week Range
3.35
-81.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues53.2M59.9M72.7M100.8M
 
 
 
 
 
Cost of Goods Sold--6.3M22.2M26.7M
 
 
 
 
Depreciation And Amortization225.0K1.7M9.5M9.7M
 
 
 
 
 
 
Operating ExpensesGross Income--51.9M41.0M64.4M
 
 
 
 
General Expenses80.8M142.0M116.9M122.7M
 
 
 
 
 
Other Operating Expenses0.000.000.001.3M
 
 
Research And Development70.6M87.1M82.4M85.7M
 
 
 
 
 
Total Operating Expenses81.0M150.0M148.6M160.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.8M-90.1M-76.0M-59.5M
 
 
 
 
 
Other Expenses16.0K29.0K-78.0K23.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.0M-88.4M-75.2M-59.0M
 
 
 
 
 
Income Taxes0.00-28.3M-2.8M-845.0K
 
 
 
 
Net Income-26.0M-60.1M-72.4M-58.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.0M69.4M117.1M118.3M
 
 
 
 
 
Shares To Calculate EPS Diluted57.0M69.4M117.1M118.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.46-$0.87-$0.62-$0.49
 
 
 
 
 
EPS Diluted-$0.46-$0.87-$0.62-$0.49